Background Analysis: US FDA Advisory Committee to Discuss Clinical Trial Development for Antibacterial Products – DEC 4, 2014 (AIDAC)

The US FDA has scheduled an Anti-Infective Drugs Advisory Committee (AIDAC) Meeting for Thursday, December 4, 2014 to discuss issues related to clinical development programs and clinical trial designs for antibacterial products for the treatment of patients with serious bacterial infections for which there are limited or no therapeutic options.

See the SAC Tracker Report